Georgia Capital PLC (GRGCF) (Q4 2025) Earnings Call Highlights: Robust Growth and Strategic Moves

GuruFocus News

Wed, February 25, 2026 at 4:00 AM GMT+9 3 min read

In this article:

CGEO.L

+2.22%

This article first appeared on GuruFocus.

Release Date: February 24, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Georgia Capital PLC (GRGCF) reported a strong EBITDA growth of nearly 18% in Q4 2025, indicating robust performance across its private large portfolios.

The company completed a $50 million buyback program and initiated a new $50 million share buyback, reflecting confidence in its financial health.

The GDP per capita in Georgia more than doubled over the past five years, contributing to a favorable macroeconomic environment.

The company's insurance business achieved record high performance with a 23% revenue growth for the full year 2025.

Georgia Capital PLC (GRGCF) maintained a strong liquidity position with a net cash position of approximately $40 million.

Negative Points

The company faces potential risks from oversupply in the real estate market, which could impact future investments.

There is uncertainty regarding the continuation or adjustment of the capital return program beyond 2026.

The retail pharmacy segment experienced a decrease in implied multiples, which could affect future valuations.

The textile retail business exit slightly affected headline growth, indicating challenges in certain business segments.

The company remains cautious about leveraging at the Holdco level, which may limit its investment capacity in the short term.

Q & A Highlights

Warning! GuruFocus has detected 6 Warning Signs with GRGCF.

Is GRGCF fairly valued? Test your thesis with our free DCF calculator.

Q: With the discount narrowing, should we expect Georgia Capital to be more aggressive with investments, particularly in boltons and larger acquisitions? Also, is there consideration to look outside Georgia for investments? A: We prefer to be pragmatic and diligent rather than aggressive. While the narrowing discount opens up more opportunities, we are cautious and do not want to force investments. We are more bullish on boltons for our large portfolio companies and are open to opportunities outside Georgia, particularly in neighboring countries. (Unidentified_1)

Q: Regarding the capital return program, with a small amount remaining, is there a preference for spending it on bond retirement or buybacks? A: Both options are on the table. If the NAV discount remains around 25%, we might prefer buybacks. A clearer picture of our capital return policy will emerge towards the end of 2026. (Unidentified_1)

Q: Is there a limit on the weight of Lion Finance within the portfolio, and would exceeding this limit trigger sales? A: There is no specific limit. Our decisions are driven by the PFI, and we manage our balance sheet and investments accordingly. (Unidentified_1)

La historia continúa  

Q: Given strong cash generation, wouldn’t it make sense to maintain some level of leverage? A: We prefer to keep leverage low at the Holdco level to avoid double leverage. We might use leverage for significant investments but would need a clear deleveraging path. (Unidentified_1)

Q: What are the ways to increase utilization in healthcare services, and what margins are possible at higher utilization levels? A: We aim to increase market share, attract new doctors and patients, and optimize bed usage. We believe a 25% EBITDA margin is achievable in the mid-term, supported by increased outpatient revenue. (Unidentified_4)

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Condiciones y Política de privacidad

Privacy Dashboard

More Info